Monitor for imminent pricing announcement or prospectus supplement, which would indicate when shares will be offered and at what price. Be aware that shelf offerings can create a dilution overhang.
GENB drugs
GENB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 27 $12.65entry
- T+1 · 9mo ago −3.79%α −3.85% · $12.17
- T+5 · 9mo ago −11.38%α −9.40% · $11.21
- T+20 · 8mo ago −9.57%α −2.01% · $11.44
- T+60 · 6mo ago +5.45%α −3.93% · $13.34
Price Chart
How similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable. This is an EFFECT filing for Generate Biomedicines, Inc. (GENB), indicating that a previously filed securities offering registration has become effective. The company can now proceed with the sale of securities, but details such as offering size, price, and timing are not available in the metadata.
Key Facts
- Filing type is EFFECT, meaning a registration statement has become effective with the SEC.
- Company: Generate Biomedicines, Inc. (GENB).
- No document content available to determine offering specifics such as size, pricing, or use of proceeds.
Financial Impact
Not specified
Risk Factors
- Potential for near-term share dilution if a follow-on or shelf offering is executed.
- Lack of transparency due to unavailable filing content limits ability to assess financial impact.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
11 reports on GENB
5 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +14.28% at T+20 after the Oct 1, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Bearish 5/10 Entry $12.57 Now $10.49 +16.55% settles Dec 11
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $12.57 Now $10.49 −16.55% settles Dec 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $13.85 Now $10.49 −24.26% settles Dec 2
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $14.46 Now $10.49 −27.46% settles Nov 30
- Oct 13, 20264w ago Press Release Bullish 6/10 Entry $12.52 to $13.49 Now $10.49 −16.21% ▲ +7.75% +9.02% vs SPY
- Oct 1, 20266w ago Press Release Bullish 5/10 Entry $13.80 to $15.77 Now $10.49 −23.99% ▲ +14.28% +13.57% vs SPY
- May 7, 202627w ago 8-K Bearish 6/10 Entry $13.59 to $12.91 Now $10.49 +22.81% ▲ +5.00% +8.14% vs SPY
- Mar 2, 202637w ago Insider Cluster Bullish 7/10 Entry $11.93 to $12.50 Now $10.49 −12.07% ▲ +4.78% +9.19% vs SPY
- Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $11.93 to $12.50 Now $10.49 −12.07% ▲ +4.78% +9.19% vs SPY
- Feb 27, 202637w ago 424B4 Bearish 7/10 Entry $12.17 to $11.51 Now $10.49 +13.80% ▲ +5.42% −2.52% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers